Hematology

Filter

CRISPR Edited AML Transplant Shows Safe Engraftment

CRISPR Edited AML Transplant Shows Safe Engraftment

May 2026

A gene edited AML transplant strategy achieved rapid engraftment and supported targeted maintenance therapy without prolonged high grade cytopenias in high risk disease.

Study Shows Positive Long-Term Safety of CAR-T Cell Therapy in B Cell Lymphoma

CAR T-cell therapy for B-cell lymphoma shows a positive long-term safety profile with few late complications.

Sickle Cell Disease Therapies Remain Underused Despite Proven Benefits

Recent research highlights the significant underuse of disease-modifying therapies for sickle cell disease, despite their established benefits in reducing pain and preventing organ damage.

High-Risk Genetic Markers Predict Poor Outcomes in Multiple Myeloma

Multiple myeloma patients with two or more high-risk genetic abnormalities face significantly poorer outcomes, regardless of disease stage or treatment.

Gender and Age Affect Bleeding Risk in Anticoagulant Treatment

Bleeding risk from anticoagulants varies by gender and age in venous thromboembolism treatment, especially during the initial phase.

Study Finds Donor Choice Influences Haploidentical Stem Cell Transplant Success

Donor age and cell dose significantly influence outcomes in haploidentical stem cell transplants, reveals new research.

Study Finds Sickle Cell Trait Not Linked to Exertion-Related Death

New research finds no evidence linking sickle cell trait to acute pain crises or sudden death during exertion.

Daratumumab-Based Quadruplet Regimen Sets New Benchmark in Myeloma Treatment

A Phase III trial shows adding daratumumab to VRd enhances treatment response in transplant-ineligible multiple myeloma patients.

Nonselective β-Blocker Use Linked to Mortality After Stem Cell Transplantation

Nonselective β-blockers may impair haematopoietic regeneration after transplantation, particularly with post-transplant chemotherapy.

Loading posts...

« Previous 1 … 18 19 20 21 22 … 50 Next »